Cresilon
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $25M
Investors
- 3
About Cresilon
Cresilon, Inc. is dedicated to developing hemostatic technology for medical applications.00 mn.Cresilon, Inc. specializes in the development and commercialization of hemostatic technology for both veterinary and human medical applications. The company’s flagship product, VETIGEL®, is a single-use, prescription hemostatic gel designed specifically for veterinary use, effectively controlling bleeding within seconds upon contact with a wound. This plant-based gel utilizes proprietary polymers that form a mechanical seal, eliminating the need for manual pressure, thereby supporting the natural clotting process in animals. Cresilon’s product offerings extend beyond VETIGEL®, focusing on trauma and surgical care solutions for both veterinary and human markets, with ongoing research and development aimed at expanding its product line.Cresilon generates revenue primarily through the sale of its medical device products, specifically focusing on veterinary applications. Transactions typically occur through direct sales to veterinary clinics and hospitals, establishing partnerships that enable wider distribution of VETIGEL® and its planned future products. The pricing structure for products like VETIGEL® is set as a single transaction per unit, aligning with the needs of veterinary practitioners who require immediate, reliable solutions for controlling bleeding in animals. The revenue model is designed to facilitate direct purchasing from Cresilon, with potential future avenues for subscription or partnership agreements as the product line expands.In December 2021, Cresilon, Inc. Cresilon aims to launch new products designed for the human medical market and is targeting expansion into additional geographical regions including Europe and Asia by 2023.
Who invested in Cresilon
3 investors across 3 rounds
See all investors in Cresilon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cresilon
Who invested in Cresilon?
Cresilon has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cresilon raised?
Cresilon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cresilon last raise money?
Cresilon's most recent round on record is a Series A, in Dec 2021.
What does Cresilon do?
Cresilon is a biotechnology company.
Where is Cresilon headquartered?
Cresilon is headquartered in Brooklyn, US.
Which VCs invest in companies like Cresilon?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cresilon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cresilon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.